Clinical Trial Update: Immunotoxin Therapy in Treating Children With Recurrent Malignant Gliomas [Phase 1, Phase 2]

View source ↗

Summary

The Phase 1/2 clinical trial evaluating immunotoxin therapy for children with recurrent malignant gliomas has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Malignant Glioma

Drugs mentioned

• Immunotoxin therapy

Snippet

Sponsor: Pediatric Brain Tumor Consortium | Conditions: Brain and Central Nervous System Tumors | Phase 1, Phase 2 | Status: WITHDRAWN